| VARIABLES | NUMBERS (n = 331) | PERCENTAGE |
| Profile |
|
|
| HIV 1 | 296 | 89.4% |
| HIV 2 | 23 | 7% |
| HIV 1 and 2 | 12 | 3.6% |
| Median BMI (kg/m2) (Std Dev) | 19.36 ± 4.4 |
|
| WHO Stage |
|
|
| Stage 1 | 84 | 25.4% |
| Stage 2 | 60 | 18.1% |
| Stage 3 | 116 | 35% |
| Stage 4 | 71 | 21.5% |
| Median CD4 (cell/mm3) (Std Dev) | 217 ± 187 |
|
| CD4 |
|
|
| <200 | 155 | 47% |
| 200 - 349 | 93 | 28% |
| 350 - 499 | 43 | 13% |
| >500 | 40 | 12% |
| Median VL in cp/ml (n = 165) (Std Dev) | 97.000 ± 70.759 |
|
| Median Creatinine (mg/l) (Std Dev) | 8 ± 5.6 |
|
| Antigenemia HBS (n = 98) |
|
|
| Positive | 05 | 5% |
| Negative | 93 | 95% |
| Median Hemoglobin (g/dl) (Std Dev) | 11 ± 1.9 |
|
| Therapeutic protocols |
|
|
| 2NRTI/1NNRTI | 292 | 88% |
| 2NRTI/1PI | 37 | 11% |
| 3NRTI | 2 | 1% |